COSCIENS Biopharma Inc. - Common Stock CSCI 深 滬

Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million

Transaction Advances Company's 'Three-S' Plan to Streamline its Portfolio and Strengthen Focus on its 'High-Grow' Brands Total Consideration of Up to €327 Million, Consisting of €300 Million...

07-14 20:30

Perrigo To Scale And Optimize Global Category-Led, Market Activation Growth Model

Roberto Khoury, EVP & President Consumer Self-Care International (CSCI), Appointed to New Position of EVP & Chief Commercial Officer to Lead Global Market ActivationTriona Schmelter, EVP & President Consumer

07-02 04:34

Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance

Company to Scale and Optimize Global Category-Led, Market Activation Growth Model Roberto Khoury, EVP & President Consumer Self-Care International (CSCI), Appointed to New Position of EVP & ...

07-02 04:30

COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders

COSCIENS Biopharma Inc. held its virtual annual general and special meeting (AGSM) where shareholders voted on key matters. Five directors—Peter H. Puccetti, Anthony J. Giovinazzo, Ulrich Kosciessa, Robert A. Seager, and David Spear—were elected with high approval rates (88.89% to 88.92%). Ronald W. Miller was elected with 68.75% approval. Deloitte LLP was appointed as the auditor, and the Amended and Restated Shareholder Rights Plan was approved...

06-30 22:33

COSCIENS Biopharma reconstitutes board

COSCIENS Biopharma (NASDAQ:CSCI) announced that Peter Puccetti has been appointed Board Chair; key board committees have also been restructured. Source: Press release More on COSCIENS Biopharma Inc. F...

05-31 05:24

COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders

COSCIENS Biopharma Inc. announces the consensual reconstitution of its board of directors to better create value for shareholders. The Reconstituted Board now includes six directors: Anthony J. Giovinazzo, Ulrich Kosciessa, Ronald W. Miller, Peter H. Puccetti, Robert A. Seager, and David Spear. The board aims to strengthen corporate governance and review the company's prospects. Goodwood Inc. agrees to support the re-election of these directors, ...

05-30 21:00

COSCIENS Biopharma Receives Director Nominations from Goodwood

COSCIENS Biopharma ( ($TSE:CSCI) ) has provided an update. COSCIENS Biopharma I...

05-26 19:07

COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders

05-26 10:50

COSCIENS Biopharma Completes Merger with Ceapro and Restructures Governance

COSCIENS Biopharma ( ($TSE:CSCI) ) has shared an update. COSCIENS Biopharma Inc...

05-21 05:47

COSCIENS Biopharma Reports Revenue Growth and Strategic Repositioning

The latest update is out from COSCIENS Biopharma ( ($TSE:CSCI) ). COSCIENS Biop...

04-10 05:43